Double germline variants in different cancer predisposition genes: a laboratory’s summary of findings

Laboratory experience reporting trisomy 16 and 22 from cell-free DNA screening: Diagnostic and clinical outcome data over a four-year period

Genome-wide cfDNA testing: Clinical laboratory experience screening for select microdeletions

Cell free DNA testing at 9 weeks: A clinical laboratory experience

Maternal fragile sites resulting in maternal mosaic deletions: an additional explanation for false positive cell-free DNA